Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Celestino Rodríguez,1 Trinidad García,1 Débora Areces,1,2 Estrella Fernández,1 Marcelino García-Noriega,3 Joan Carles Domingo41Department of Psychology, Faculty of Psychology, University of Oviedo, Oviedo, Spain; 2Child Education Program, Facult...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rodríguez C, García T, Areces D, Fernández E, García-Noriega M, Domingo JC
Format: article
Langue:EN
Publié: Dove Medical Press 2019
Sujets:
Omega 3
PUFAs
Eicosapentaenoic Acid (EPA)
docosahexaenoic acid (DHA)
Attention Deficit Hyperactivity Disorder (ADHD)
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Accès en ligne:https://doaj.org/article/708e34b9af7940a7b045ab3b4c50a0cd
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/708e34b9af7940a7b045ab3b4c50a0cd

Documents similaires